P. Korkolopoulou et al., B-CELL LYMPHOMA OF LARGE MULTILOBATED TYPE - AN IMMUNOHISTOCHEMICAL STUDY OF 8 CASES AND REVIEW OF THE LITERATURE, Leukemia & lymphoma, 13(1-2), 1994, pp. 151-159
Large multilobated cell lymphomas represent an heterogenous group comp
rising both B-cell and T-cell subtypes. The correct lineage identifica
tion of each subtype cannot be based on morphologic grounds, as it has
already been stressed by other authors, and demands the use of immuno
phenotyping methods. In this study we review the literature and presen
t eight new cases of large multilobated B-cell lymphoma which have bee
n immunophenotyped in paraffin sections with a panel of monoclonal [L(
26) (CD20), 4KB5 (CD45R), UCHL1 (CD45RO), MT1 (CD43)] and polyclonal (
anti-CD3, anti-kappa anti-lambda) antibodies. We further investigated
the expression of c-myc p62 oncoprotein and of proliferating cell nucl
ear antigen (PCNA) using the monoclonal antibodies c-myc 1-9E10 and PC
-10 respectively. In all cases the neoplastic cells were positive for
L26 (CD20) and negative for anti-CDS. Five cases were positive for 4KB
5 (CD45R) while six cases stained positively for UCHL1 (CD45RO) or MT1
(CD43). Four cases were monoclonal in respect to light chain restrict
ion. Immunoreactivity with c-myc 1-9E10 and PC-10 was observed in all
cases. As far as c-myc 1-9E10 is concerned, positive cells constituted
more than 45% of the neoplastic population in six cases, whereas in a
ll cases the percentage of PC-10 positive cells was greater than 45%.
The staining pattern was nuclear and/or cytoplasmic for c-myc 1-9E10 b
ut solely nuclear for PC-10. The elevated c-myc and PCNA expression ar
e indices of high proliferation rate in this type of lymphoma and may
suggest a high malignancy grade.